Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis

Journal of Crohn's and Colitis

Volumn 6, Issue 2, 2012, Pages 226-235

  Brückner, Markus ^a   Westphal, Sabine ^b   Domschke, Wolfram ^a   Kucharzik, Torsten ^c   Lügering, Andreas ^d  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Hospital of Luneburg   (Germany)

^d Medical Care Unit Portal 10   (Germany)

Author keywords

Colitis; Epigallocatechin 3 gallate (EGCG); Green tea; Inflammatory bowel disease (IBD); Piperine; Reactive oxygen species

Indexed keywords

DEXTRAN SULFATE; EPIGALLOCATECHIN GALLATE; GLUTATHIONE PEROXIDASE; INTERLEUKIN 8; MALONALDEHYDE; PIPERINE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLACK PEPPER; CELL CULTURE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG BIOAVAILABILITY; ENZYME ACTIVITY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEUTROPHIL; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEA; WEIGHT REDUCTION;

ALKALOIDS; ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; BENZODIOXOLES; CATECHIN; COLITIS; DEXTRAN SULFATE; FEMALE; GLUTATHIONE PEROXIDASE; HT29 CELLS; HUMANS; INTERLEUKIN-8; MALONDIALDEHYDE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PEROXIDASE; PIPERIDINES; POLYUNSATURATED ALKAMIDES; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; WEIGHT LOSS;

EID: 84856728144     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.08.012     Document Type: Article

References (61)

1. Andres P.G., Friedman L.S. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 1999, 28:255-281. vii.
2. Kruidenier L., Verspaget H.W. Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease-radicals or ridiculous?. Aliment Pharmacol Ther 2002, 16:1997-2015.
3. Rezaie A., Parker R.D., Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?. Dig Dis Sci 2007, 52:2015-2021.
4. Kaplan M., Mutlu E.A., Benson M., Fields J.Z., Banan A., Keshavarzian A. Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders. Complement Ther Med 2007, 15:207-216.
5. Abboud P.A., Hake P.W., Burroughs T.J., Odoms K., O'Connor M., Mangeshkar P., Wong H.R., Zingarelli B. Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis. Eur J Pharmacol 2008, 579:411-417.
6. Mazzon E., Muia C., Paola R.D., Genovese T., Menegazzi M., De Sarro A., Suzuki H., Cuzzocrea S. Green tea polyphenol extract attenuates colon injury induced by experimental colitis. Free Radic Res 2005, 39:1017-1025.
7. Graham H.N. Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992, 21:334-350.
8. Ahn S.C., Kim G.Y., Kim J.H., Baik S.W., Han M.K., Lee H.J., Moon D.O., Lee C.M., Kang J.H., Kim B.H., Oh Y.H., Park Y.M. Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-kappaB. Biochem Biophys Res Commun 2004, 313:148-155.
9. Varilek G.W., Yang F., Lee E.Y., deVilliers W.J., Zhong J., Oz H.S., Westberry K.F., McClain C.J. Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. J Nutr 2001, 131:2034-2039.
10. Rice-Evans C.A., Miller N.J., Bolwell P.G., Bramley P.M., Pridham J.B. The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic Res 1995, 22:375-383.
11. Higdon J.V., Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003, 43:89-143.
12. Schwedhelm E., Maas R., Troost R., Boger R.H. Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress. Clin Pharmacokinet 2003, 42:437-459.
13. Nanjo F., Goto K., Seto R., Suzuki M., Sakai M., Hara Y. Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl-2-picrylhydrazyl radical. Free Radic Biol Med 1996, 21:895-902.
14. Feng W.Y. Metabolism of green tea catechins: an overview. Curr Drug Metab 2006, 7:755-809.
15. Vaidyanathan J.B., Walle T. Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes. Drug Metab Dispos 2002, 30:897-903.
16. Vaidyanathan J.B., Walle T. Cellular uptake and efflux of the tea flavonoid (-)epicatechin-3-gallate in the human intestinal cell line caco-2. J Pharmacol Exp Ther 2003, 307:745-752.
17. Hong J., Lambert J.D., Lee S.H., Sinko P.J., Yang C.S. Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites. Biochem Biophys Res Commun 2003, 310:222-227.
18. Lambert J.D., Lee M.J., Lu H., Meng X., Hong J.J., Seril D.N., Sturgill M.G., Yang C.S Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J Nutr 2003, 133:4172-4177.
19. Lambert J.D., Hong J., Kim D.H., Mishin V.M., Yang C.S. Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice. J Nutr 2004, 134:1948-1952.
20. Sies H. Strategies of antioxidant defense. Eur J Biochem 1993, 215:213-219.
21. Esworthy R.S., Aranda R., Martin M.G., Doroshow J.H., Binder S.W., Chu F.F. Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am J Physiol Gastrointest Liver Physiol 2001, 281:G848-G855.
22. Grisham M.B., MacDermott R.P., Deitch E.A. Oxidant defense mechanisms in the human colon. Inflammation 1990, 14:669-680.
23. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997, 336:1066-1071.
24. Rao R., Baker R.D., Baker S.S. Inhibition of oxidant-induced barrier disruption and protein tyrosine phosphorylation in caco-2 cell monolayers by epidermal growth factor. Biochem Pharmacol 1999, 57:685-695.
25. Gutteridge J.M. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995, 41:1819-1828.
26. Banan A., Choudhary S., Zhang Y., Fields J.Z., Keshavarzian A. Oxidant-induced intestinal barrier disruption and its prevention by growth factors in a human colonic cell line: role of the microtubule cytoskeleton. Free Radic Biol Med 2000, 28:727-738.
27. Yakes F.M., Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 1997, 94:514-519.
28. Rao R.K., Baker R.D., Baker S.S., Gupta A., Holycross M. Oxidant-induced disruption of intestinal epithelial barrier function: role of protein tyrosine phosphorylation. Am J Physiol 1997, 273:G812-G823.
29. Pravda J. Radical induction theory of ulcerative colitis. World J Gastroenterol 2005, 11:2371-2384.
30. Simmonds N.J., Allen R.E., Stevens T.R., Van Someren R.N., Blake D.R., Rampton D.S. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 1992, 103:186-196.
31. Grisham M.B., Volkmer C., Tso P., Yamada T. Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology 1991, 101:540-547.
32. Shin H.Y., Kim S.H., Jeong H.J., Kim S.Y., Shin T.Y., Um J.Y., Hong S.H., Kim H.M. Epigallocatechin-3-gallate inhibits secretion of TNF-alpha, IL-6 and IL-8 through the attenuation of ERK and NF-kappaB in HMC-1 cells. Int Arch Allergy Immunol 2007, 142:335-344.
33. Porath D., Riegger C., Drewe J., Schwager J. Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell lines. J Pharmacol Exp Ther 2005, 315:1172-1180.
34. Fujiki H., Suganuma M., Okabe S., Sueoka N., Komori A., Sueoka E., Kozu T., Tada Y., Suga K., Imai K., Nakachi K. Cancer inhibition by green tea. Mutat Res 1998, 402:307-310.
35. Crespy V., Williamson G. A review of the health effects of green tea catechins in in vivo animal models. J Nutr 2004, 134:3431S-3440S.
36. Wang Z.Y., Cheng S.J., Zhou Z.C., Athar M., Khan W.A., Bickers D.R., Mukhtar H. Antimutagenic activity of green tea polyphenols. Mutat Res 1989, 223:273-285.
37. Dieleman L.A., Palmen M.J., Akol H., Bloemena E., Pena A.S., Meuwissen S.G., Van Rees E.P. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 1998, 114:385-391.
38. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
39. Mullane K.M., Kraemer R., Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985, 14:157-167.
40. Wiseman S.A., Balentine D.A., Frei B. Antioxidants in tea. Crit Rev Food Sci Nutr 1997, 37:705-718.
41. Keshavarzian A., Sedghi S., Kanofsky J., List T., Robinson C., Ibrahim C., Winship D. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology 1992, 103:177-185.
42. Monte M., Davel L.E., Sacerdote de Lustig E. Hydrogen peroxide is involved in lymphocyte activation mechanisms to induce angiogenesis. Eur J Cancer 1997, 33:676-682.
43. Kruidenier L., Kuiper I., Lamers C.B., Verspaget H.W. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 2003, 201:28-36.
44. Cao W., Vrees M.D., Kirber M.T., Fiocchi C., Pricolo V.E. Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 2004, 286:G833-G843.
45. Riedle B., Kerjaschki D. Reactive oxygen species cause direct damage of Engelbreth-Holm-Swarm matrix. Am J Pathol 1997, 151:215-231.
46. Lin Y.L., Lin J.K. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol Pharmacol 1997, 52:465-472.
47. Marklund S.L. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J 1984, 222:649-655.
48. Halliwell B., Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br J Pharmacol 2004, 142:231-255.
49. MacMillan-Crow L.A., Crow J.P., Kerby J.D., Beckman J.S., Thompson J.A. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA 1996, 93:11853-11858.
50. Pigeolet E., Corbisier P., Houbion A., Lambert D., Michiels C., Raes M., Zachary M.D., Remacle J. Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech Ageing Dev 1990, 51:283-297.
51. Mulder T.P., Verspaget H.W., Janssens A.R., de Bruin P.A., Pena A.S., Lamers C.B. Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease. Gut 1991, 32:1146-1150.
52. Ohyashiki T., Ohtsuka T., Mohri T. A change in the lipid fluidity of the porcine intestinal brush-border membranes by lipid peroxidation. Studies using pyrene and fluorescent stearic acid derivatives. Biochim Biophys Acta 1986, 861:311-318.
53. Chiarpotto E., Scavazza A., Leonarduzzi G., Camandola S., Biasi F., Teggia P.M., Garavoglia M., Robecchi A., Roncari A., Poli G. Oxidative damage and transforming growth factor beta 1 expression in pretumoral and tumoral lesions of human intestine. Free Radic Biol Med 1997, 22:889-894.
54. Curzio M., Esterbauer H., Poli G., Biasi F., Cecchini G., Di Mauro C., Cappello N., Dianzani M.U. Possible role of aldehydic lipid peroxidation products as chemoattractants. Int J Tissue React 1987, 9:295-306.
55. Na H.K., Kim E.H., Jung J.H., Lee H.H., Hyun J.W., Surh Y.J. (-)-epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells. Arch Biochem Biophys 2008, 476:171-177.
56. Na H.K., Surh Y.J. Intracellular signaling network as a prime chemopreventive target of (-)-epigallocatechin gallate. Mol Nutr Food Res 2006, 50:152-159.
57. Ahmed S., Marotte H., Kwan K., Ruth J.H., Campbell P.L., Rabquer B.J., Pakozdi A., Koch A.E. Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. Proc Natl Acad Sci USA 2008, 105:14692-14697.
58. Luo D., Min W., Lin X.F., Wu D., Xu Y., Miao X. Effect of epigallocatechingallate on ultraviolet B-induced photo-damage in keratinocyte cell line. Am J Chin Med 2006, 34:911-922.
59. Bae G.S., Kim M.S., Jung W.S., Seo S.W., Yun S.W., Kim S.G., Park R.K., Kim E.C., Song H.J., Park S.J. Inhibition of lipopolysaccharide-induced inflammatory responses by piperine. Eur J Pharmacol 2010, 642:154-162.
60. Sano J., Inami S., Seimiya K., Ohba T., Sakai S., Takano T., Mizuno K. Effects of green tea intake on the development of coronary artery disease. Circ J 2004, 68:665-670.
61. Su L.J., Arab L. Tea consumption and the reduced risk of colon cancer - results from a national prospective cohort study. Public Health Nutr 2002, 5:419-425.